What Does NAD Therapy Address?
There are three degenerative diseases of the brain that can gain support through NAD IV therapy. In my training at Springfield Wellness Center, I learned that and 8-day stent of NAD helps regenerate nerve cells. We see improved memory with NAD if done regularly.
Apparently, we can help Parkinson’s and Multiple Sclerosis patient with an 8-day protocol, however we haven’t had the privilege of treating these conditions yet. For those who may wish to use the therapy for Alzheimer’s Disease, Parkinson’s Disease or Multiple Sclerosis we will honor a 30% discount for the 8-day therapy. We may or may not see a cure however we know with chronic illness that late stage illnesses are linked with low NAD levels.
Traumatic Brain Injury
A key pathophysiological process and therapeutic target in the critical early post-injury period of traumatic brain injury (TBI) is cell mitochondrial dysfunction. Some literature supports that NAD repletion may support brain energy metabolism in select TBI patients suffering from mitochondrial dysfunction.
Through NAD treatment, our goal is to help you address the root causes of your symptoms for optimal, long-term healing. NAD IV’s are used to both potentially prevent and reverse these conditions. Our Brain Restoration NAD may be the path toward helping you begin to recover and feel like yourself again.
References
- Wang X, He H-J, Xiong X, Zhou S et al.NAD in Alzheimer’s Disease: Molecular Mechanisms and Systematic Therapeutic Evidence Obtained in vivo. Cell Dev. Biol. 9:668491. Doi:10.3389/fcell.2021.668491
- Geriatrics 2024. Highlighted Grant. Elevating NAD levels in Brain May Improve Aging. Prevent Alzheimer’s Disease (Research Updates)
- Rutherford L, et al., 2020. Intravenous Administration of Nicotinamide Adenine Di- nucleotide Alleviates Tremors Associated with Parkinson’s Disease: A Case Report6:047 DOI: 10.24966/GGM-8662/100047 HSOA Journal of Gerontology & Geriatric Medicine
- Wang, J., Runxuan, Sun, Runxuan., Xia, Linhan et al. Potential Therapeutic Effects of NAMPT-Mediated NAD Biosynthesis in Depression In Vivo. Brain Sci. 2022, 12, 1699. https://doi.org/10.3390/brainsci12121699
- Vamshi K.C. Nimmagadda, Tapas K. Makar, Krish Chandrasekaran, et al. SIRT1 and NAD + precursors: Therapeutic targets in multiple sclerosis a review. Journal of Neuroimmunology, Vol 304, 15 March 2017, 29-35
- Matthew G. Stovell, Marius O. Mada, Adel Helmy, et al. The effect of succinate on brain NADH/NAD+ redox state and high energy phosphate metabolism in acute traumatic brain injury. Scientific Reports | (2018) 8:11140 | DOI:10.1038/s41598-018-29255-3
